Your browser doesn't support javascript.
loading
Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy.
Kambhampati, Swetha; Sheng, Ying; Huang, Chiung-Yu; Bylsma, Sophia; Lo, Mimi; Kennedy, Vanessa; Natsuhara, Kelsey; Martin, Thomas; Wolf, Jeffrey; Shah, Nina; Wong, Sandy W.
Afiliação
  • Kambhampati S; Division of Hematology/Oncology, Department of Medicine.
  • Sheng Y; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center.
  • Huang CY; Department of Epidemiology and Biostatistics.
  • Bylsma S; Department of Epidemiology and Biostatistics.
  • Lo M; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center.
  • Kennedy V; Department of Pharmacy and.
  • Natsuhara K; Division of Hematology/Oncology, Department of Medicine.
  • Martin T; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center.
  • Wolf J; Department of Medicine, UCSF Medical Center, San Francisco, CA.
  • Shah N; Division of Hematology/Oncology, Department of Medicine.
  • Wong SW; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center.
Blood Adv ; 6(7): 2045-2054, 2022 04 12.
Article em En | MEDLINE | ID: mdl-34543400
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Mieloma Múltiplo Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Mieloma Múltiplo Idioma: En Ano de publicação: 2022 Tipo de documento: Article